NMDA receptor modulator 9
NMDA receptor modulator 9 is an orally active NMDA receptor positive allosteric modulator (PAM). NMDA receptor modulator 9 enhances GluN2A receptor activity. NMDA receptor modulator 9 demonstrates significant antidepressant-like effects in chronic restraint stress (CRS)-induced depression mice. NMDA receptor modulator 9 can be used for the study of depression.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C19H20FN3O2S
- Masse moléculaire:373.44
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform iGluR
More
Activité biologique
Description
In Vitro
NMDA receptor modulator 9 (Compound Y36) (30 μM) significantly enhances GluN2A receptor-mediated currents only when coadministered with both glutamate and Glycine (HY-Y0966) in Xenopus oocytes expressing GluN1/GluN2A[1].
NMDA receptor modulator 9 shows higher efficacy (Emax = 397.7%) than GNE-3419 (Emax = 196.4%), reducing the EC50 values and increasing the Emax values for glutamate/Glycine at GluN2A receptor[1].
NMDA receptor modulator 9 (200 μM) exhibits no significant cytotoxicity in HEK293, PC12, and SH-SY5Y cell lines[1].
NMDA receptor modulator 9 exhibits weak affinity for the hERG channel with an IC50 of 67.85 μM, indicating low risk of cardiac toxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Parmacokinetics
| Species | Dose | Route | Note | Cmax | Tmax | T1/2 | AUC0-t | MRT0-t | F | CL | Vss |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 12 mg/kg | p.o. | / | 3242.61 ng/mL | 0.25 h | 0.89 h | 3946.98 ng·h/mL | 1.16 h | 70.67 % | / | / |
| Mice[1] | 4 mg/kg | i.v. | / | 1567.97 ng/mL | 0.083 h | 0.72 h | 1861.57 ng·h/mL | 0.90 h | / | 35.36 mL/min/kg | 2.08 L/kg |
| Mice[1] | 8 mg/kg | i.p. | plasma | 1430.44 ng/mL | 0.333 h | 1.15 h | 1986.59 ng·h/mL | 1.11 h | / | / | / |
| Mice[1] | 8 mg/kg | i.p. | brain | 5129.81 ng/mL | 0.25 h | 0.90 h | 4926.40 ng·h/mL | 0.93 h | / | / | / |
In Vivo
NMDA receptor modulator 9 (Compound Y36) (200-350 mg/kg, p.o., single dose) exhibits slow mortality with an LD50 of 270.82 mg/kg in male C57BL/6J mice[1].
NMDA receptor modulator 9 (0.3-1.0 mg/kg, i.p., every 2 days for 30 days) causes no abnormal behavior, stable body weight, no significant changes in organ/body weight ratios, and no obvious nephrotoxicity, hepatotoxicity or myocardial injury in ICR mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J mice (subjected to 4 h daily restraint stress for 28 days)[1]
-
Dosage:0.1, 0.3, 1.0 mg/kg
-
Administration:i.p. or p.o.for a single dose
-
Result:Increased central area entries in OFT.
Reduced immobility time in TST.
Enhanced sucrose preference in SPT (alleviating anhedonia).
Chemical Information
-
Masse moléculaire 373.44
-
Formule C19H20FN3O2S
-
SMILES
FC1=CC=C(C2(O)CCN(CC3=CC(N4C=C(SC4=N3)C)=O)CC2)C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
NMDA receptor modulator 9 Related Classifications
HY-175508 Related Classifications
Powered by Bioz